Raj, Ranjan, et al. “Randomized Phase III Trial Comparing Epirubicin Doxorubicin Plus Docetaxel and Epirubicin Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer”. Journal for Research in Applied Sciences and Biotechnology, vol. 2, no. 3, June 2023, pp. 55-63, doi:10.55544/jrasb.2.3.8.